Care

This Series C comes less than a year after the startup closed its $200 million Series B in 2020.

NurX CEO Varsha Rao on the female-focused telehealth company's expansion from contraception to dermatology, migraines and more.

While these features are built to be used by all working families on the Cleo platform, it’s those families who do face discrimination who will benefit the most.   

The company currently has 11 locations delivering virtual-supported care, but now plans to open "several" more in the first half of 2021.  

Truepill inked a deal with Health Transformation Alliance in order to offer its new services to the latter's members. 

The collaboration will augment AI with remote care automation to improve patient care.

The company's technology looks to reduce the burden on pathologists reviewing digital slides, while also serving as a safety net to reduce errors.

The startup will now move onto a larger pivotal trial of the neuromodulation therapy, which received a Breakthrough Device Designation from the FDA in January.

Value-based care implies radical, even disruptive changes to the current practice, say Paulus Torkki, associate professor of healthcare operations management at University of Helsinki and Marianna Imenokhoeva, founder of LinktoMedicine and HIMSS Future50 Leader. 

Providers will be able to have in-app live video conversations with chronic pain and movement disorder patients, as well as prescribe new settings for their neuromodulation therapies from afar.